Thrombosis research, 2020-09, Vol.193, p.166-169
- Trimaille, Antonin
- Curtiaud, Anaïs
- Marchandot, Benjamin
- Matsushita, Kensuke
- Sato, Chisato
- Leonard-Lorant, Ian
- Sattler, Laurent
- Grunebaum, Lelia
- Ohana, Mickaël
- Von Hunolstein, Jean-Jacques
- Andres, Emmanuel
- Goichot, Bernard
- Danion, François
- Kaeuffer, Charlotte
- Poindron, Vincent
- Ohlmann, Patrick
- Jesel, Laurence
- Morel, Olivier
2020
Details
- Autor(en) / Beteiligte
- Trimaille, Antonin
- Curtiaud, Anaïs
- Marchandot, Benjamin
- Matsushita, Kensuke
- Sato, Chisato
- Leonard-Lorant, Ian
- Sattler, Laurent
- Grunebaum, Lelia
- Ohana, Mickaël
- Von Hunolstein, Jean-Jacques
- Andres, Emmanuel
- Goichot, Bernard
- Danion, François
- Kaeuffer, Charlotte
- Poindron, Vincent
- Ohlmann, Patrick
- Jesel, Laurence
- Morel, Olivier
- Titel
- Venous thromboembolism in non-critically ill patients with COVID-19 infection
- Ist Teil von
- Thrombosis research, 2020-09, Vol.193, p.166-169
- Ort / Verlag
- United States: Elsevier Ltd
- Erscheinungsjahr
- 2020
- Link zum Volltext
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- [Display omitted] •Venous thromboembolism (VTE) is a frequent complication in COVID-19 patients.•Single-center study of COVID-19 patients admitted to general ward.•17.0% of patients with VTE•Lack of thromboprophylaxis and leukocytosis were independent risk factors of VTE.•VTE is independently associated with worse in-hospital outcomes.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0049-3848eISSN: 1879-2472DOI: 10.1016/j.thromres.2020.07.033Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7367026
- Format
- –
- Schlagworte
- Acute pulmonary embolism, Aged, Anticoagulants - therapeutic use, Betacoronavirus - drug effects, Betacoronavirus - isolation & purification, Coronavirus Infections - blood, Coronavirus Infections - complications, Coronavirus Infections - drug therapy, Coronavirus Infections - virology, COVID-19, Deep vein thrombosis, Enoxaparin - therapeutic use, Female, Fondaparinux - therapeutic use, Heparin - therapeutic use, Humans, Male, Middle Aged, Pandemics, Pneumonia, Viral - blood, Pneumonia, Viral - complications, Pneumonia, Viral - drug therapy, Pneumonia, Viral - virology, Retrospective Studies, SARS-CoV-2, Treatment Outcome, Venous thromboembolism, Venous Thromboembolism - blood, Venous Thromboembolism - drug therapy, Venous Thromboembolism - etiology, Venous Thromboembolism - virology